From: Seasonal variations in fatigue in persons with rheumatoid arthritis: a longitudinal study
Variable | mean ± SD median (max;min) | n (%) | |
---|---|---|---|
Age (years) | 54 ± 9.9 |  | |
56 (23;66) | |||
Sex, female | Â | 48 (74Â %) | |
Disease duration (years) | 15 ± 9.6 |  | |
12 (4;45) | |||
DAS-28 (score) | 3.7 ± 1.4 |  | |
3.8 (0.8;6.9) | |||
Tender joints (n) | 6.7 ± 6.3 |  | |
5 (0;27) | |||
Swollen joints (n) | 3.9 ± 4.1 |  | |
3 (0;21) | |||
Erythrocyte sedimentation rate (mm) | 10.9 ± 10.2 |  | |
7 (2;53) | |||
Global, VAS 0–100 (mm) | 36 ± 22.7 |  | |
32 (1;83) | |||
Pain, VAS 0–100 (mm) | 38 ± 25.5 |  | |
34 (0;100) | |||
HAQ (score) | 0.6 ± 0.6 |  | |
0.6 (0;2.4) | |||
Medication | Â | Â | |
 | No DMARD |  | 8 (12 %) |
 | Conventional synthetic DMARD | 57 (88 %) | |
 | Biological DMARD |  | 15 (23 %) |
 | Corticosteroids |  | 7 (11 %) |
Work status | Â | Â | |
 | Working or studying (full-time or part-time) | 41 (63 %) | |
 | Unemployed |  | 7 (11 %) |
 | Retired |  | 6 (9 %) |
 | Disability benefits (full-time or part-time) | 24 (37 %) | |
 | Parent’s allowance | 2 (3 %) |